Secukinumab provides sustained reduction in fatigue in patients with active psoriatic arthritis through 3 years: long-term data from the future 1 and future 2 studies
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
| Original language | English |
|---|---|
| Article number | SAT0463 |
| Journal | Annals of the Rheumatic Diseases |
| Volume | 76 |
| Issue number | Suppl 2 |
| Pages (from-to) | 949 |
| ISSN | 0003-4967 |
| DOIs | |
| Publication status | Published - 2017 |
ID: 195764919